INKON Life Technology Co Ltd (300143) - Net Assets
Based on the latest financial reports, INKON Life Technology Co Ltd (300143) has net assets worth CN¥2.58 Billion CNY (≈ $377.78 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.15 Billion ≈ $607.42 Million USD) and total liabilities (CN¥1.57 Billion ≈ $229.64 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check INKON Life Technology Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.58 Billion |
| % of Total Assets | 62.19% |
| Annual Growth Rate | 22.85% |
| 5-Year Change | 10.61% |
| 10-Year Change | 66.99% |
| Growth Volatility | 142.91 |
INKON Life Technology Co Ltd - Net Assets Trend (2007–2024)
This chart illustrates how INKON Life Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore INKON Life Technology Co Ltd total assets for the complete picture of this company's asset base.
Annual Net Assets for INKON Life Technology Co Ltd (2007–2024)
The table below shows the annual net assets of INKON Life Technology Co Ltd from 2007 to 2024. For live valuation and market cap data, see market cap of INKON Life Technology Co Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.48 Billion ≈ $362.66 Million |
+73.45% |
| 2023-12-31 | CN¥1.43 Billion ≈ $209.08 Million |
+8.46% |
| 2022-12-31 | CN¥1.32 Billion ≈ $192.77 Million |
-27.04% |
| 2021-12-31 | CN¥1.81 Billion ≈ $264.20 Million |
-19.42% |
| 2020-12-31 | CN¥2.24 Billion ≈ $327.88 Million |
+63.86% |
| 2019-12-31 | CN¥1.37 Billion ≈ $200.10 Million |
-33.85% |
| 2018-12-31 | CN¥2.07 Billion ≈ $302.49 Million |
-15.02% |
| 2017-12-31 | CN¥2.43 Billion ≈ $355.97 Million |
+10.79% |
| 2016-12-31 | CN¥2.20 Billion ≈ $321.31 Million |
+47.95% |
| 2015-12-31 | CN¥1.48 Billion ≈ $217.17 Million |
+331.47% |
| 2014-12-31 | CN¥343.97 Million ≈ $50.33 Million |
-46.53% |
| 2013-12-31 | CN¥643.30 Million ≈ $94.14 Million |
-20.66% |
| 2012-12-31 | CN¥810.78 Million ≈ $118.64 Million |
+3.17% |
| 2011-12-31 | CN¥785.85 Million ≈ $114.99 Million |
+8.09% |
| 2010-12-31 | CN¥727.00 Million ≈ $106.38 Million |
+521.87% |
| 2009-12-31 | CN¥116.90 Million ≈ $17.11 Million |
+43.35% |
| 2008-12-31 | CN¥81.55 Million ≈ $11.93 Million |
+8.90% |
| 2007-12-31 | CN¥74.89 Million ≈ $10.96 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to INKON Life Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7610.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥3.83 Billion | 157.52% |
| Total Equity | CN¥2.43 Billion | 100.00% |
INKON Life Technology Co Ltd Competitors by Market Cap
The table below lists competitors of INKON Life Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Under Armour Inc C
NYSE:UA
|
$1.23 Billion |
|
YFY Inc
TW:1907
|
$1.23 Billion |
|
G-III Apparel Group Ltd
NASDAQ:GIII
|
$1.24 Billion |
|
Sichuan Chuanhuan Technology Co Ltd
SHE:300547
|
$1.24 Billion |
|
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
|
$1.23 Billion |
|
Treehouse Foods Inc
NYSE:THS
|
$1.23 Billion |
|
Biotage AB
ST:BIOT
|
$1.23 Billion |
|
Henan Yicheng New Energy Co Ltd
SHE:300080
|
$1.23 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INKON Life Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,381,668,862 to 2,430,580,107, a change of 1,048,911,245 (75.9%).
- Net income of 115,423,812 contributed positively to equity growth.
- Dividend payments of 8,617,253 reduced retained earnings.
- Other factors increased equity by 942,104,685.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥115.42 Million | +4.75% |
| Dividends Paid | CN¥8.62 Million | -0.35% |
| Other Changes | CN¥942.10 Million | +38.76% |
| Total Change | CN¥- | 75.92% |
Book Value vs Market Value Analysis
This analysis compares INKON Life Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.47x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.59x to 3.47x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥4.34 | CN¥11.25 | x |
| 2018-12-31 | CN¥3.73 | CN¥11.25 | x |
| 2019-12-31 | CN¥2.45 | CN¥11.25 | x |
| 2020-12-31 | CN¥3.44 | CN¥11.25 | x |
| 2021-12-31 | CN¥2.76 | CN¥11.25 | x |
| 2022-12-31 | CN¥2.00 | CN¥11.25 | x |
| 2023-12-31 | CN¥2.15 | CN¥11.25 | x |
| 2024-12-31 | CN¥3.24 | CN¥11.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently INKON Life Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.75%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.40%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 1.46x
- Recent ROE (4.75%) is above the historical average (-2.00%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 13.27% | 16.43% | 0.43x | 1.87x | CN¥2.45 Million |
| 2008 | 14.06% | 15.51% | 0.45x | 2.01x | CN¥3.31 Million |
| 2009 | 17.41% | 21.25% | 0.43x | 1.92x | CN¥8.66 Million |
| 2010 | 5.81% | 25.13% | 0.20x | 1.17x | CN¥-30.50 Million |
| 2011 | 7.49% | 28.35% | 0.25x | 1.06x | CN¥-19.73 Million |
| 2012 | 0.85% | 2.62% | 0.25x | 1.31x | CN¥-69.79 Million |
| 2015 | 0.73% | 3.78% | 0.15x | 1.28x | CN¥-133.62 Million |
| 2016 | 2.55% | 12.74% | 0.17x | 1.17x | CN¥-160.97 Million |
| 2017 | 5.15% | 37.18% | 0.13x | 1.10x | CN¥-115.36 Million |
| 2018 | 2.46% | 9.95% | 0.19x | 1.28x | CN¥-153.95 Million |
| 2019 | -52.56% | -122.77% | 0.29x | 1.46x | CN¥-837.25 Million |
| 2020 | 5.80% | 19.38% | 0.25x | 1.20x | CN¥-92.92 Million |
| 2021 | -20.53% | -33.41% | 0.44x | 1.39x | CN¥-541.44 Million |
| 2022 | -46.44% | -51.54% | 0.57x | 1.58x | CN¥-724.23 Million |
| 2023 | 7.27% | 6.83% | 0.61x | 1.74x | CN¥-37.73 Million |
| 2024 | 4.75% | 7.40% | 0.44x | 1.46x | CN¥-127.63 Million |
Industry Comparison
This section compares INKON Life Technology Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,118,810,426
- Average return on equity (ROE) among peers: 16.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INKON Life Technology Co Ltd (300143) | CN¥2.58 Billion | 13.27% | 0.61x | $1.23 Billion |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $1.09 Billion | 22.08% | 0.18x | $449.34 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $6.16 Billion | 12.22% | 0.29x | $4.30 Billion |
| Double Medical Technology Inc (002901) | $1.46 Billion | 25.48% | 0.14x | $2.63 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $615.62 Million | 6.75% | 0.04x | $577.41 Million |
| Lepu Medical Tech Beijing (300003) | $3.29 Billion | 12.85% | 0.16x | $3.87 Billion |
| Edan Instruments Inc (300206) | $152.19 Million | 30.16% | 0.31x | $1.26 Billion |
| Guangdong Biolight Meditech Co Ltd (300246) | $1.03 Billion | 33.51% | 0.56x | $685.28 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.80 Billion | 0.85% | 0.07x | $534.16 Million |
| Sinocare Inc (300298) | $3.47 Billion | 8.19% | 0.71x | $1.36 Billion |
About INKON Life Technology Co Ltd
INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of prevention / diagnosis / treatment / rehabilitation, providing medical services for tumors in China and internationally. It provides medical devices solution for radiotherapy, life support, image enhancement, and chronic disease treatment, as well as oncology medical services. The company was formerly known as… Read more